05/06/2020 / By Ethan Huff
In order to expedite the release of a new vaccine for the Wuhan coronavirus (COVID-19), deep state scientists are pushing to begin so-called “challenge” trials on healthy participants to test the efficacy of the most promising jab candidates.
Since it normally takes years to develop and gain approval for new vaccines – and the establishment is demanding a vaccine now – “cutting corners,” to quote USA Today, is necessary to bring to market a Wuhan coronavirus (COVID-19) vaccine much more quickly than the normal process would allow.
With challenge trials, healthy participants are administered the live virus on purpose, meaning they could become infected with the Wuhan coronavirus (COVID-19) and possibly die as part of the medical experiment. But this is required for the “greater good,” claim those in support of a rushed vaccine.
According to reports, tens of thousands of healthy people will be vaccinated as part of these challenge trials before being sent out into the world, possibly infecting others with the novel virus due to vaccine “shedding.” Scientists will then observe who gets sick and who recovers.
To further speed up the process, some volunteers will be given both experimental vaccines and a subsequent infection with the Wuhan coronavirus (COVID-19), just to see what happens.
“You’re weighing risks and benefits to the individual versus benefit to society as a whole,” claims David Magnus, director of the Stanford Center for Biomedical Ethics at Stanford University.
Listen below to The Health Ranger Report as Mike Adams, the Health Ranger, discusses how many mainstream media outlets are herding their viewers and readers into accepting this rushed-to-market vaccine once it becomes available:
Since time is of the essence for the vaccine industry, which stands to reap untold billions from the mass administration of Wuhan coronavirus (COVID-19) vaccines, pro-vaccine researchers and scientists are rushing to get these experimental vaccine candidates to Phase III trials as quickly as possible.
While it would normally take several years to get to this point, those pulling the strings are making it happen this year, if possible, as part of President Donald Trump’s “Operation Warp Speed” effort to deliver a commercial vaccine for the Wuhan coronavirus (COVID-19) before the end of 2020.
The U.S. Food and Drug Administration (FDA) is evaluating how it will handle this unprecedented effort to skip all of the normal safety testing and basically fill the vials and start administering them as soon as possible.
“A formal determination about any specific human challenge trial proposal would be made by the FDA in the context of all the information that is available at that time,” stated FDA spokesman Michael Felberbaum.
A Phase III trial, in case you are not familiar, involves administering an experimental vaccine to tens of thousands of human guinea pigs. It is the final step before a vaccine gains commercial approval, which vaccine worshipers are hoping will happen in accordance with Trump’s “warp speed” timeline.
“Phase III trials are the primary source of data that helps us know whether we have a vaccine we can use at a broad scale,” says Jason Schwartz, a professor who studies vaccine policy at the Yale University School of Public Health.
In the case of vaccines for the Wuhan coronavirus (COVID-19), scientists are aiming to conduct Phases I-III all at the same time before demanding that the FDA grant its blessing. The FDA is said to be working closely with each of the companies involved in trying to produce a new vaccine for the novel virus.
More of the latest news about the Wuhan coronavirus (COVID-19) is available at Pandemic.news.
Sources for this article include:
Tagged Under: Big Pharma, China, Chinese Virus, coronavirus, covid-19, disease, experiments, global emergency, Global Pandemic, guinea pigs, human guinea pigs, infection, live viruses, medical ethics, medical experiments, novel coronavirus, outbreak, pandemic, vaccine, virus, Wuhan, Wuhan coronavirus
Vaccines.News is a fact-based public education website published by Vaccines News Features, LLC.
All content copyright © 2018 by Vaccines News Features, LLC.
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.